BioSpace News Archive

Drug Development

VistaGen Announces Topline Results from PALISADE-1 Phase 3 Clinical Trial for Investigational Drug PH94B

VistaGen Therapeutics, Inc. today announced topline results from its PALISADE-1 Phase 3 clinical trial of PH94B for the acute treatment of anxiety in adults with social anxiety disorder.

July 22, 2022
·
7 min read
Genetown

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Bardet-Biedl Syndrome

Rhythm Pharmaceuticals, Inc. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to expand the current marketing authorization for IMCIVREE.

July 22, 2022
·
10 min read
Business

Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the preprint in ResearchGate of case study #8 entitled “A Case Review.

July 22, 2022
·
7 min read
Policy

FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health

The U.S. Food and Drug Administration prioritizes the health and safety of American consumers and patients as well as animals and uses a variety of tools for the appropriate oversight of FDA-regulated products and establishments.

July 22, 2022
·
5 min read
Blood Testing Market Size to Worth Around US$ 94.7 Billion by 2030

The global Blood Testing market size is expected to be worth around US$ 94.7 billion by 2030 from valued at US$ 60.9 billion in 2020 and is anticipated to grow at a CAGR of 16.6% from 2021 to 2030.

July 22, 2022
·
5 min read
Endodontic Devices Market Size, Trends, Growth, Report 2022-2030

According to Vision Research Reports, the global Endodontic Devices market size is expected to hit around US$ 2.7 billion by 2030 and is projected to grow at a registered CAGR of 5% from 2021 to 2030.

July 22, 2022
·
6 min read
NuGen Announces Offering and Closing of First Tranche of Private Placement

NuGen Medical Devices Inc. announces that it has closed the first tranche of a non-brokered private placement through the issuance of 4,118,000 units at a price of $0.10 per Unit for gross proceeds of $411,800.

July 22, 2022
·
4 min read
PreveCeutical Enters into Credit Facility Agreement

Pursuant to the Agreement, the Lenders have consolidated certain outstanding principal and accrued interest for existing credit facilities with the Company, and have transferred an aggregate of $2,448,785.75 to the Agreement.

July 22, 2022
·
6 min read
Pharm Country

Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced Linear

Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA-Based Therapeutics Summit.

July 22, 2022
·
5 min read
Biotech Beach

Pre-Clinical Intake Automation Company Health Note Nabs $17M in Funding Round

Health Note, the pre-clinical intake automation platform that uses digital patient intake to prepare clinical notes for providers ahead of patient visits, today announces the close of a $17 million Series A financing round led by SignalFire.

July 22, 2022
·
5 min read